Thrivent Financial For Lutherans Dr Reddys Laboratories LTD Transaction History

Thrivent Financial For Lutherans

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$61.9 - $72.77 $6,685 - $7,859	-108 Reduced 0.36%	29,935 $2 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $846,719 - $1 Million	15,874 Added 112.03%	30,043 $1.9 Million
Q4 2022 Feb 08, 2023	BUY	$51.15 - $57.45 $724,744 - $814,009	14,169 New	14,169 $733,000
Q4 2020 Feb 16, 2021	SELL	$62.61 - $71.29 $321,690 - $366,288	-5,138 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$51.39 - $72.41 $940,950 - $1.33 Million	-18,310 Reduced 78.09%	5,138 $357,000
Q2 2020 Aug 12, 2020	SELL	$39.55 - $54.65 $437,027 - $603,882	-11,050 Reduced 32.03%	23,448 $1.24 Million
Q1 2020 May 15, 2020	BUY	$34.75 - $45.85 $206,866 - $272,945	5,953 Added 20.85%	34,498 $1.39 Million
Q4 2019 Feb 13, 2020	BUY	$36.66 - $41.78 $755,965 - $861,545	20,621 Added 260.23%	28,545 $1.16 Million
Q3 2019 Nov 14, 2019	BUY	$34.82 - $39.26 $275,913 - $311,096	7,924 New	7,924 $300,000

245

23.1M

12.7K

6.1K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.61B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.